About viveve medical inc - VIVE
Viveve Medical, Inc. engages in the design, development, manufacture, and marketing of platform medical technology. It offers cryogen-cooled monopolar radio frequency technology, which delivers through a radiofrequency generator, hand piece and treatment tip. The Viveve system is a non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company was founded on March 3, 1987 and is headquartered in Englewood, CO.
VIVE At a Glance
Viveve Medical, Inc.
345 Inverness Drive South
Englewood, Colorado 80112
| Phone | 1-720-696-8100 | Revenue | 6.43M | |
| Industry | Medical Specialties | Net Income | -22,027,000.00 | |
| Sector | Health Technology | 2021 Sales Growth | 17.284% | |
| Fiscal Year-end | 12 / 2022 | Employees | 47 | |
| View SEC Filings |
VIVE Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 1.79 |
| Price to Book Ratio | 0.804 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 0.097 |
| Enterprise Value to Sales | -0.309 |
| Total Debt to Enterprise Value | -2.861 |
VIVE Efficiency
| Revenue/Employee | 136,723.404 |
| Income Per Employee | -468,659.574 |
| Receivables Turnover | 11.705 |
| Total Asset Turnover | 0.302 |
VIVE Liquidity
| Current Ratio | 4.906 |
| Quick Ratio | 4.581 |
| Cash Ratio | 4.227 |
VIVE Profitability
| Gross Margin | -7.828 |
| Operating Margin | -335.403 |
| Pretax Margin | -338.796 |
| Net Margin | -342.779 |
| Return on Assets | -103.552 |
| Return on Equity | -199.882 |
| Return on Total Capital | -106.195 |
| Return on Invested Capital | -135.827 |
VIVE Capital Structure
| Total Debt to Total Equity | 37.674 |
| Total Debt to Total Capital | 27.365 |
| Total Debt to Total Assets | 21.904 |
| Long-Term Debt to Equity | 36.181 |
| Long-Term Debt to Total Capital | 26.28 |